CORONAVIRUS NEWS

Sakura Finetek and Evident Scientific have announced a collaboration to offer a full workflow solution for anatomic pathology slide preparation and high-resolution digital scanning in the Americas.

Roche has announced the launch of its next-generation portfolio SARS-CoV-2 rapid antigen tests (“2.0”) for self-testing and professional use in countries accepting the CE Mark. Distribution of the new rapid test portfolio is projected to begin in the coming weeks.

Software platform helps keep pace with rising demand for pathology services as US labour shortage intensifies.

Linkam Scientific Instruments has opened the doors at its new UK premises in Redhill, Surrey, UK, on the occasion of its 40th anniversary in temperature-controlled microscopy.

Eleanor Corbett has joined Cherwell’s expert team of cleanroom microbiology sales specialists.

PathFlow viewer and automated workflow are now European regulatory cleared for use in primary diagnosis.

Roche has launched Anti-PRAME (EPR 20330) rabbit monoclonal primary antibody to identify PRAME protein expression in tissue samples from patients with suspected melanoma.

US Food and Drug Administration (FDA) clearance introduces first immunohistochemistry IHControls panel for evaluating breast cancers.

Laboratory information systems (LIS) company NovoPath has released enhanced integrated workflows for genetic and molecular testing.

The Gel-Bright laser diode gel illuminator is more sensitive than blue LED illuminators for red dyes, without UV hazards.

Providing a quick diagnosis of methicillin resistance at the point of care, the latest addition to the Vivalytic portfolio of tests not only provides rapid RT-PCR results in 53 minutes but differentiates between methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive S. aureus (MSSA), which promotes targeted therapy.

ViroStat has introduced new antibodies to enable the quicker detection of Gram-negative bacteria.

The new global brand, known as Clinisys, serves over 3,000 customers in 34 countries.

A welcome from Pathology in Practice's new editor...

New research has found that there is a link between non-coding DNA and certain neurological disorders such as Alzheimer’s and motor neuron disease.

LogicBio Therapeutics, a pioneering clinical-stage genomic medicine company, has announced that it has entered into a definitive agreement under which AstraZeneca Rare Disease will acquire the company.

Catapult Health and Tasso have joined forces to use the Tasso+ self-sampling blood collection device as part of an annual healthcare checkup for employees of some of the USA’s largest corporations and major national health plans.

DNA sequencing and array-based technologies company Illumina has launched the NovaSeq X Series of new production-scale sequencers that will push the limits of what is possible with genomic medicine, enabling faster, more powerful, and more sustainable sequencing.

A pathology partnership performing 32 million tests a year has been relaunched as ‘Synnovis’ – officially heralding the start of a new era for clinicians and patients in south-east London.

The Advancing Healthcare Awards recognise and celebrate the work of allied health professionals, healthcare scientists and those who work alongside them in support roles, leading innovative healthcare practice across the UK.